The majority of patients with asthma can achieve disease control with standard therapy. However, approximately 5-10% suffer from severe, inadequately controlled asthma. Biological therapy is a promising targeted therapeutic option for such patients with severe asthma. These targeted therapies have been shown to reduce asthma exacerbations, improve lung function, reduce oral corticosteroid use, and improve the quality of life in selected patients.
Join proficient Interventional Pulmonologist Dr. Sameer Bansal in our exclusive session on “Biological Therapy in Severe Asthma” on 29 th April 2025 , 6:00 PM IST onwards. Stay tuned! Suggested readings USFDA Approves Omalizumab-igec Biosimilar for Asthma The First New Treatment for Asthma Exacerbation in 50 Years Exercise During Pregnancy Linked to Reduced Asthma Risk in Children ##Disclaimer## The content provided on Docplexus is intended…
